Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4901 - 4925 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP03
  • B-IV antigen(d18:1/20:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261846 2994.43061 C130H227N5O71
Gangliosides LMSP0601AU08
  • GQ1c(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262131 2529.272469 C114H196N6O55
Glycosyldiacylglycerols LMGL05010068
  • 1-(9Z-octadecenoyl)-2-(9,10-methylene-octadecanoic acid)-3-O-alpha-D-glucosyl-sn-glycerol
  • 1-oleoyl-2-Dihydrosterculoyl-3-O-alpha-D-glucosyl-sn-glycerol
171118822 796.60645 C46H84O10
Fatty acyl glycosides of mono- and disaccharides LMFA13010064
  • 1-Octen-3-yl primeveroside
  • 2-(oct-1-en-3-yloxy)-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
24094121 168671 422.2152 C19H34O10
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261627 1307.869329 C68H125NO22
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AJ04
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type IV A antigen(d18:1/22:0)
44260239 1822.033952 C86H155N3O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261620 1169.728479 C58H107NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA07
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261858 1279.838029 C66H121NO22
LMSL03000757
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-2'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT18(22:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52930594 2145.885455 C135H252O17
LMSL03000916
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-docosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
  • PAT18(25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
52930753 2201.948055 C139H260O17
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AW07
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260346 1781.991419 C84H151NO38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE04
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • SSEA-3 antigen(d18:1/22:0)
44260199 1472.896668 C72H132N2O28
Fatty acyl glycosides of mono- and disaccharides LMFA13010030
  • 1-(O-alpha-D-glucopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol
42607364 131694 674.533285 C38H74O9
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AI05
  • Fucalpha1-2Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type III H antigen(d18:1/24:0)
44261040 1996.123162 C94H169N3O41
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AJ05
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type IV A antigen(d18:1/24:0)
44260240 1850.065252 C88H159N3O37
Diacylglycosylglycerophospholipids LMGP14010005
  • 1-(11Z-octadecenoyl)-2-(hexadecenoyl)-sn-glycero-3-phospho-2'-alpha-D-6-glucosaminyl-sn-glycerol
138454235 909.594247 C46H88NO14P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA08
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Gb3(d18:1/26:1(17Z))
44260171 133816 1161.811419 C62H115NO18
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030004
  • Am-PE(P-18:0/18:1(9Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine
171119255 893.635717 C47H92NO12P
LMSL03001050
  • 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-alpha,alpha-trehalose
  • PAT18(26:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S]))
52930887 2197.95314 C140H260O16
Rhamnolipids LMFA13030018
  • 3-O-alpha-L-rhamnopyranosyl-3-hydroxy-5Z-tetradecenoyl-3-hydroxydecanoic acid
171119031 558.376785 C30H54O9
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC00
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
  • Lewis a
GSG1166 90292
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BA02
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • trimeric LeY-9(d18:1/18:0)
44261181 2058.087172 C94H167N3O45
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AY07
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261170 2562.319085 C116H203N5O56
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN04
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260591 1351.870392 C68H125N3O23
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BF01
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261220 1794.961516 C82H146N4O38

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024